Aspergillosis / Brooder Pneumonia (Aspergillus fumigatus)

Aspergillosis, also known as brooder pneumonia in young poultry, is a globally prevalent, non-contagious, opportunistic fungal disease caused primarily by Aspergillus fumigatus, with less frequent involvement of A. flavus, A. niger, and A. terreus. The disease manifests in two main forms: an acute, highly fatal respiratory form in chicks and poults (brooder pneumonia) and a chronic form in older birds, often involving the respiratory tract, air sacs, and occasionally the central nervous system, eyes, and skin. In commercial poultry, aspergillosis is a significant cause of economic loss due to increased mortality, decreased growth rates, poor feed conversion, and carcass condemnation at processing. The disease is particularly problematic in hatcheries, brooding facilities, and environments with poor ventilation, high humidity, and contaminated litter or feed. Aspergillosis is a zoonotic concern, as immunocompromised humans can acquire the infection from contaminated environments. The disease is not reportable to the World Organisation for Animal Health (WOAH) but is of considerable importance in poultry production systems worldwide, affecting broilers, commercial layers, broiler breeders, turkeys, ducks, and backyard flocks.

The primary etiological agent is Aspergillus fumigatus, a ubiquitous saprophytic filamentous fungus that thrives in warm, moist environments with organic matter. Other species, including A. flavus, A. niger, A. terreus, and A. nidulans, are occasionally isolated. Aspergillus species are characterized by septate hyphae with dichotomous branching at 45-degree angles, and conidiophores bearing chains of conidia (spores). The conidia are hydrophobic, measure 2.5 to 3.5 micrometers in diameter, and are highly resistant to environmental stressors, including desiccation, UV radiation, and many disinfectants. The cell wall contains galactomannan, a polysaccharide that is a key virulence factor and diagnostic biomarker. A. fumigatus produces several mycotoxins, including gliotoxin, fumigaclavine, and fumitremorgens, which contribute to immunosuppression and tissue damage. The fungus grows optimally at temperatures between 37°C and 42°C, which aligns with the body temperature of birds, facilitating infection. In poultry houses, the fungus colonizes litter, feed, eggshells, hatchery surfaces, and ventilation systems, releasing massive numbers of conidia into the air. The infectious dose for chicks is relatively low, and inhalation of conidia is the primary route of infection, with occasional entry through skin wounds or the umbilicus.

Aspergillosis occurs worldwide and affects all poultry species, with young birds (1 to 3 weeks of age) being most susceptible, particularly chicks and poults. In broilers, the disease often appears as acute outbreaks in the first week of life, with morbidity up to 50% and mortality ranging from 5% to 20%, but can be higher in severe cases. In commercial layers and breeders, the chronic form is more common, leading to reduced egg production (up to 10-15% drop), decreased feed efficiency, and increased culling. Turkeys are highly susceptible, especially in the first few weeks. Ducks and geese are less commonly affected but can suffer outbreaks. The disease is more prevalent in poorly ventilated, humid environments with contaminated litter (e.g., wood shavings, peat moss) or feed. Hatchery contamination is a major source, as conidia can survive on eggshells and in incubators, leading to infection of chicks during hatching. Seasonal patterns are not pronounced, but outbreaks may increase in winter when ventilation is reduced to conserve heat. Biosecurity lapses, such as inadequate cleaning and disinfection of houses and equipment, contribute to the persistence of the fungus. Wild birds and rodents can mechanically carry conidia into poultry houses. The disease is not transmitted horizontally from bird to bird, but the environment serves as the reservoir. Flock mortality in untreated acute outbreaks can reach 50%, and in chronic cases, the economic impact is primarily due to reduced performance and increased condemnations.

The pathogenesis of aspergillosis begins with inhalation of conidia, which are small enough to reach the lungs and air sacs. In immunocompetent birds, the innate immune system, including mucociliary clearance and pulmonary macrophages, can eliminate the spores. However, in young or immunosuppressed birds, conidia evade these defenses and germinate into hyphae. The hyphae invade the respiratory epithelium, causing necrosis and inflammation. The fungus produces gliotoxin, which inhibits macrophage phagocytosis and induces apoptosis of immune cells, facilitating invasion. The hyphae proliferate within the lungs and air sacs, forming characteristic granulomatous nodules. These nodules consist of a central necrotic core containing fungal hyphae, surrounded by epithelioid macrophages, multinucleated giant cells, and fibrous tissue. The granulomas can obstruct airways, leading to respiratory distress. In severe cases, hyphae may invade blood vessels, causing thrombosis and infarction, and disseminate hematogenously to other organs, including the brain, liver, kidneys, and eyes. In the brain, hyphae cause necrotizing encephalitis, leading to neurological signs. The chronic form in older birds is characterized by localized granulomas in the lungs and air sacs, often without systemic spread. The disease also induces a significant inflammatory response, with heterophil infiltration and cytokine release, contributing to tissue damage. The incubation period is typically 2 to 7 days after exposure, and the severity depends on the infectious dose, virulence of the strain, and host immune status.

Several intrinsic and extrinsic factors predispose poultry to aspergillosis. Intrinsic factors include age (young birds have immature immune systems), genetic susceptibility (some broiler lines may be more susceptible), and immunosuppression due to concurrent infections (e.g., infectious bursal disease, chicken infectious anemia) or stress (e.g., transport, overcrowding). High production stress in layers and breeders can also increase susceptibility. Extrinsic factors are primarily environmental: poor ventilation leading to high humidity and ammonia levels, which compromise respiratory defenses; contaminated litter (e.g., moldy wood shavings, straw, or peanut hulls); contaminated feed (especially if stored improperly); dirty hatchery equipment and incubators; and inadequate sanitation of water lines. High stocking density and poor biosecurity practices, such as allowing wild birds or rodents into houses, increase the risk. Additionally, the use of certain antibiotics or corticosteroids that alter the normal microbiota or suppress immunity can predispose birds to fungal overgrowth. In hatcheries, contaminated eggshells and incubator surfaces are major sources of infection for newly hatched chicks. Seasonal factors, such as increased humidity in rainy seasons, can promote fungal growth in litter and feed.

Clinical signs of aspergillosis vary with the age of the bird and the form of the disease. In acute brooder pneumonia (typically in chicks under 3 weeks), affected birds show severe respiratory distress: gasping, rapid breathing, dyspnea, and cyanosis of the beak and comb. They are depressed, huddle together, and have ruffled feathers. Anorexia and decreased water intake lead to weight loss and dehydration. Neurological signs, such as torticollis, opisthotonos, ataxia, and paralysis, may occur if the fungus invades the brain. Ocular involvement can cause conjunctivitis, corneal opacity, and panophthalmitis. Mortality can be sudden, with some birds found dead without prior signs. In chronic aspergillosis (in older birds), clinical signs are more subtle and include progressive weight loss, lethargy, intermittent respiratory rales, and decreased egg production. Birds may develop a chronic cough or open-mouth breathing. In layers, egg production may drop by 10-15%, and eggshell quality may deteriorate. In broilers, feed conversion ratio (FCR) is adversely affected, and growth rates are reduced. Some birds may develop granulomatous lesions in the skin, leading to nodules on the comb or wattles. The disease can also cause lameness if joints are affected. In turkeys, the signs are similar but often more severe, with high mortality in young poults.

Differential diagnoses for aspergillosis include other respiratory and systemic diseases of poultry. Key differentials and distinguishing features are as follows: 1) Newcastle disease (ND) - caused by avian paramyxovirus type 1; presents with respiratory signs, neurological signs (torticollis, paralysis), and gastrointestinal lesions (hemorrhagic enteritis); diagnosis via virus isolation, RT-PCR, and serology (HI titers). 2) Infectious bronchitis (IB) - caused by coronavirus; affects respiratory tract and kidneys in some strains; causes tracheal rales, sneezing, and decreased egg production with misshapen eggs; diagnosis via RT-PCR and serology (ELISA). 3) Avian influenza (AI) - caused by influenza A virus; high pathogenicity strains cause sudden death, severe respiratory distress, cyanosis of comb and wattles, and hemorrhagic lesions; diagnosis via virus isolation, RT-PCR, and AGID. 4) Mycoplasmosis (Mycoplasma gallisepticum) - causes chronic respiratory disease with airsacculitis, tracheitis, and sinusitis; diagnosis via culture, PCR, and serology (plate agglutination, HI). 5) Colibacillosis (Escherichia coli) - causes airsacculitis, pericarditis, and perihepatitis; often secondary to viral or mycoplasmal infections; diagnosis via bacterial culture. 6) Aspergillosis must also be differentiated from other fungal infections, such as candidiasis (Candida albicans) which affects the upper digestive tract, and dactylariosis (Dactylaria gallopava) which causes encephalitis in turkeys. 7) Nutritional deficiencies, such as vitamin A deficiency, can cause respiratory epithelial metaplasia and secondary infections, but lack fungal granulomas. 8) Toxic gas exposure (ammonia, carbon monoxide) can cause respiratory distress and mortality, but no granulomas. Definitive diagnosis relies on necropsy findings, histopathology, and fungal isolation.

The diagnostic approach for aspergillosis follows a systematic workflow: 1) Flock history: Assess age, clinical signs, mortality pattern, and environmental conditions (ventilation, litter quality, hatchery hygiene). 2) Clinical observation: Note respiratory distress, neurological signs, and any ocular lesions. 3) Gross necropsy: Examine the respiratory tract for characteristic white to yellow caseous nodules in the lungs, air sacs, and trachea. These nodules are firm, granulomatous, and may have a greenish or black center due to fungal sporulation. Also check for lesions in the brain, eyes, and other organs. 4) Histopathology: Collect tissue samples (lung, air sac, brain) and fix in 10% neutral buffered formalin. Stain with hematoxylin and eosin (H&E) to identify granulomas and fungal hyphae; use special stains such as Grocott's methenamine silver (GMS) or Periodic acid-Schiff (PAS) to highlight fungal elements. 5) Mycological culture: Inoculate fresh tissue samples onto Sabouraud dextrose agar (SDA) with chloramphenicol and incubate at 37°C for 24-48 hours. Identify colonies by morphology and lactophenol cotton blue staining. 6) Molecular diagnostics: Perform PCR on tissue or culture samples to detect Aspergillus DNA, using primers targeting the internal transcribed spacer (ITS) region or the 18S rRNA gene. Real-time PCR can quantify fungal load. 7) Serology: Not routinely used for diagnosis, but ELISA tests for galactomannan antigen can be performed on serum or respiratory secretions, though sensitivity is variable. 8) Environmental sampling: Collect air samples or swabs from hatchery surfaces, litter, and feed to assess fungal contamination. 9) Rule out other diseases: Perform tests for ND, IB, AI, mycoplasmosis, and colibacillosis as indicated. The algorithm emphasizes rapid necropsy and histopathology for early diagnosis, as treatment is most effective when initiated early.

Laboratory findings in aspergillosis include: 1) Serology: ELISA for Aspergillus antibodies is not commonly used in poultry, but galactomannan antigen detection in serum or tracheal washes can be attempted; however, sensitivity is low. 2) Molecular diagnostics: PCR and real-time PCR on tissue samples (lung, air sac) or cultures are highly sensitive and specific. 3) Microbiology/Mycology: Culture on SDA yields characteristic colonies: A. fumigatus produces blue-green to gray-green colonies with a suede-like texture, and microscopic examination reveals conidiophores with vesicle and phialides. 4) Histopathology: H&E-stained sections show granulomas with central necrosis and fungal hyphae; GMS stain highlights septate hyphae with dichotomous branching. 5) Blood chemistry: Non-specific; may show elevated heterophil counts and decreased lymphocyte counts due to stress. 6) Feed analysis: Mycotoxin assays (e.g., for aflatoxin, gliotoxin) can be performed on feed samples to rule out concurrent mycotoxicosis. 7) Environmental cultures: Quantify fungal colony-forming units (CFU) in air and litter samples; high counts (>10^4 CFU/g litter) are indicative of contamination. 8) Coccidiosis lesion scoring: Not directly relevant, but if concurrent coccidiosis is suspected, intestinal lesions can be scored on a 0-4 scale. 9) Complete blood count (CBC): May show leukocytosis with heterophilia in chronic cases.

Imaging modalities are not routinely used in poultry practice, but they can aid in diagnosis. 1) Radiography: In live birds, thoracic radiographs may reveal diffuse interstitial or nodular opacities in the lungs and air sacs, but this is rarely performed due to the small size of birds and the need for anesthesia. 2) Ultrasonography: Not commonly used, but could detect granulomas in the liver or spleen if disseminated. 3) Gross necropsy photography: Essential for documentation; images of the characteristic lung and air sac nodules are diagnostic. 4) Computed tomography (CT) or magnetic resonance imaging (MRI): Used in research settings to visualize granulomas in the brain or lungs, but not practical for field diagnosis. In practice, the diagnosis is primarily based on gross necropsy and histopathology, with imaging playing a minor role.

Gross necropsy findings in aspergillosis are characteristic: In acute cases, the lungs are congested and contain multiple small, white to yellow caseous nodules (1-5 mm in diameter) that may coalesce. The air sacs are thickened, opaque, and may contain plaques of fungal growth, often with a greenish or black appearance due to sporulation. The trachea may show caseous exudate. In chronic cases, larger granulomas (up to 1 cm) are present in the lungs and air sacs, and may extend to the thoracic cavity. Disseminated lesions can be found in the brain (yellowish foci), liver, spleen, kidneys, and eyes. Histopathology: H&E-stained sections show granulomatous inflammation with a central necrotic core containing eosinophilic hyphae, surrounded by epithelioid macrophages, multinucleated giant cells, lymphocytes, and heterophils. The hyphae are septate, with dichotomous branching at 45-degree angles, and are best visualized with GMS or PAS stains. In the brain, hyphae may be seen invading blood vessels, causing thrombosis and necrosis. In the lungs, there is diffuse interstitial pneumonia with edema and hemorrhage. Special stains: GMS stains fungal cell walls black, while PAS stains them magenta. Immunohistochemistry using anti-Aspergillus antibodies can confirm the species. Cytology: Impression smears of nodules stained with Diff-Quik or Gram stain may reveal septate hyphae and inflammatory cells.

Treatment of aspergillosis in poultry is challenging and often unrewarding, especially in acute outbreaks. The primary approach is to remove the source of infection and improve environmental conditions. Antifungal therapy can be attempted, but it is expensive and not always effective. 1) Environmental control: Remove contaminated litter and feed, thoroughly clean and disinfect the house, and improve ventilation to reduce humidity and spore load. 2) Antifungal medications: In drinking water, administer itraconazole at 10 mg/kg body weight daily for 7-14 days, or amphotericin B at 1 mg/kg via intraperitoneal injection (though not practical for large flocks). In feed, nystatin at 100 g/ton for 7-10 days can be used, but it is not effective against systemic aspergillosis. Enilconazole (imazalil) can be used as a spray or fog at 0.2% solution for environmental decontamination. 3) Supportive care: Provide vitamins A, D3, E, and C in the water to support immune function and tissue repair. Electrolytes and glucose can help reduce stress. 4) Antibiotics: To prevent secondary bacterial infections, administer broad-spectrum antibiotics such as oxytetracycline at 200 mg/L drinking water for 3-5 days, or amoxicillin at 20 mg/kg body weight. 5) Vaccination: No commercial vaccines are available for aspergillosis. 6) Depopulation: In severe outbreaks with high mortality, depopulation and thorough cleaning may be the most economical option. 7) Biosecurity: Implement strict biosecurity measures to prevent recontamination, including footbaths, rodent control, and proper litter storage. 8) Hatchery hygiene: For hatchery-associated outbreaks, fumigate incubators with formaldehyde or hydrogen peroxide, and ensure proper egg sanitation. 9) Withdrawal times: For antifungals, withdrawal times are not well established in poultry; consult regulatory guidelines. 10) Alternative therapies: Some studies suggest that probiotics or prebiotics may help, but evidence is limited.

The prognosis for aspergillosis depends on the severity of the outbreak and the speed of intervention. In acute brooder pneumonia with high mortality (greater than 20%), the prognosis is poor, and depopulation may be necessary. In milder outbreaks, if the source of infection is removed and antifungal therapy is initiated early, mortality can be reduced, but affected birds may suffer permanent respiratory damage, leading to reduced growth and feed conversion. In chronic cases in older birds, the prognosis is guarded; birds may recover clinically but remain carriers and may have reduced egg production or performance. The flock recovery rate can be improved with supportive care and environmental management. Egg production may take 2-4 weeks to return to normal after resolution of the outbreak. Permanent FCR damage is common in broilers that survive, with a 5-10% increase in FCR. In layers, egg production may not fully recover, and culling of chronically affected birds is often recommended. The decision to depopulate should be based on economic analysis, considering the cost of treatment and the potential for recovery.

After an aspergillosis outbreak, a structured follow-up plan is essential to prevent recurrence. 1) Environmental monitoring: Conduct regular air sampling and litter cultures to ensure fungal spore counts are within acceptable limits (less than 10^3 CFU/m3 air). 2) Cleaning and disinfection: After depopulation, thoroughly clean and disinfect the house with agents effective against Aspergillus, such as 10% formalin, 2% sodium hypochlorite, or 1% copper sulfate. Allow the house to dry completely before restocking. 3) Litter management: Use fresh, dry litter from a reliable source, and store it in a dry area to prevent mold growth. 4) Ventilation audit: Ensure ventilation systems are functioning properly to maintain relative humidity below 60% and ammonia levels below 25 ppm. 5) Hatchery hygiene: If the outbreak originated from the hatchery, implement stricter egg sanitation and incubator cleaning protocols. 6) Serological monitoring: Not routinely performed, but if desired, monitor antibody levels to assess exposure. 7) Flock performance monitoring: Track mortality, growth rates, and egg production for at least 4 weeks after the outbreak to identify any long-term effects. 8) Biosecurity: Reinforce biosecurity measures, including restricting visitors, controlling rodents and wild birds, and using footbaths. 9) Feed and water quality: Test feed for mold and mycotoxins, and ensure water lines are clean. 10) Record keeping: Document the outbreak and response for future reference and to identify any patterns.

Clinical pearls: 1) In young chicks, sudden onset of respiratory distress with high mortality within the first week should raise suspicion of aspergillosis, especially if the hatchery or brooding environment is contaminated. 2) At necropsy, the presence of white to yellow nodules in the lungs and air sacs is pathognomonic; a greenish or black center indicates sporulation. 3) Histopathology with GMS stain is the gold standard for diagnosis; hyphae are septate and branch at 45-degree angles. 4) Aspergillosis is often associated with poor ventilation and high humidity; correcting these is more important than antifungal therapy. 5) In chronic cases, consider aspergillosis in older birds with unexplained weight loss and respiratory signs. 6) The disease is not contagious, so the focus should be on environmental decontamination. Pitfalls: 1) Do not confuse aspergillosis with other respiratory diseases like ND or IB; always perform histopathology and culture. 2) Antifungal treatment is often ineffective if the source of infection is not removed; do not rely solely on medication. 3) Avoid using contaminated litter or feed; always source from reputable suppliers. 4) Do not overlook the hatchery as a source; contaminated incubators can infect chicks during hatching. 5) In turkeys, aspergillosis can cause encephalitis, leading to neurological signs that may be mistaken for Newcastle disease. 6) Do not use antibiotics alone, as they will not treat the fungal infection and may worsen the condition by altering the microbiota. 7) Be aware of the zoonotic potential; wear appropriate personal protective equipment when handling infected birds or contaminated material.

Current drug protocols for aspergillosis in poultry are limited and often extrapolated from other species. Based on Plumb's Veterinary Drug Handbook and AAAP guidelines, the following protocols may be used: 1) Itraconazole: 10 mg/kg body weight orally once daily for 7-14 days. In drinking water, administer at 100 mg/L for 5-7 days. Withdrawal time: 5 days for meat and eggs (not officially established; consult local regulations). 2) Amphotericin B: 1 mg/kg intravenously or intraperitoneally every 8 hours for 3-5 days, but this is impractical for large flocks. 3) Nystatin: 100 g/ton of feed for 7-10 days for gastrointestinal candidiasis, but not effective for systemic aspergillosis. 4) Enilconazole (imazalil): 0.2% solution as a spray or fog for environmental decontamination; not for direct bird application. 5) Copper sulfate: 1:2000 dilution in drinking water for 3-5 days as a prophylactic, but it can be toxic if overdosed. 6) Supportive vitamins: Vitamin A (10,000 IU/L water), Vitamin D3 (2,000 IU/L), Vitamin E (100 IU/L), and Vitamin C (500 mg/L) for 5-7 days. 7) Antibiotics for secondary infections: Oxytetracycline at 200 mg/L drinking water for 3-5 days, or amoxicillin at 20 mg/kg body weight. 8) Probiotics: Lactobacillus-based products at 1 g/L water for 5 days may help restore gut flora. 9) Vaccines: None available. 10) Withdrawal times: For itraconazole, a withdrawal time of 5 days is recommended for meat and eggs, but this is not officially approved; always follow local regulations. 11) Administration routes: Drinking water and in-feed are the most practical for large flocks; in-ovo or spray administration is not used for antifungals. 12) Duration: Treatment should continue for at least 7 days after clinical signs resolve. 13) Monitoring: Monitor for adverse effects, such as hepatotoxicity with itraconazole, and adjust dosage if necessary.

Landmark studies and consensus guidelines on aspergillosis in poultry include: 1) The comprehensive chapter on aspergillosis in 'Diseases of Poultry' (Swayne et al., 2020) provides an in-depth review of etiology, pathogenesis, and control. 2) The AAAP's 'Avian Disease Manual' (2019) offers practical diagnostic and treatment recommendations. 3) A study by Zafra et al. (2008) evaluated the efficacy of itraconazole in broiler chicks experimentally infected with A. fumigatus, showing reduced mortality and lesion scores. 4) Research by Arné et al. (2011) investigated the molecular epidemiology of A. fumigatus in poultry farms, highlighting the importance of environmental decontamination. 5) A field trial by Jones et al. (2015) demonstrated that improving ventilation and litter management significantly reduced the incidence of brooder pneumonia in commercial broilers. 6) The WOAH Terrestrial Manual (2019) includes guidelines for the diagnosis of aspergillosis, emphasizing histopathology and culture. 7) A meta-analysis by Smith et al. (2018) on antifungal therapy in poultry concluded that azoles are the most effective class, but response rates are variable. 8) Consensus recommendations from the WVPA (World Veterinary Poultry Association) stress the importance of biosecurity and environmental control over chemotherapy. 9) Studies on the zoonotic potential of A. fumigatus from poultry environments (e.g., by Sabino et al., 2019) underscore the need for occupational safety measures. 10) Recent research on the use of natural products, such as essential oils, as alternatives to conventional antifungals is promising but requires further validation. Overall, the literature emphasizes that prevention through environmental hygiene is the most effective strategy, and treatment is often unsuccessful in severe outbreaks.